- About Us
- Our Team
KMJ is experienced in providing audit, accounting and tax services to the life sciences and biotech industry. We work with clients in many different segments of this industry, including pharmaceutical, biotechnology, compounding pharmacies, and medical devices.
Our professionals understand the unique issues of the industry. Whether you are a start-up or a mature commercial business, we have the experience to understand the accounting and tax issues facing your business, including:
Research & Development Costs (R&D)
We are familiar with outsourced R&D and collaboration arrangements, including accounting specific matters for prepaid and accrued R&D costs, and milestone payments.
Revenue Recognition and Complex Licensing Arrangements
Revenue recognition is a complex area for pharmaceutical and biotech companies, especially licensing of intellectual property. Our professionals are well versed in the various accounting pronouncements in this area.
Debt and Equity Financing Arrangements
Our professionals have extensive experience in guiding our life sciences and biotech clients through the maze of accounting pronouncements related to complex debt and equity financing transactions. These transactions include convertible preferred stock, convertible debt, and issuance of warrants. We also have extensive experience in understanding the accounting and disclosure requirements for beneficial conversion features, embedded derivative financial instruments, and stock-based compensation arrangements.
As a PCAOB registered firm, we audit publicly traded companies in the life sciences and biotech industry and have extensive knowledge and experience with the initial public offering (IPO) process and secondary offerings. We can help your organization navigate through the accounting and reporting complexities associated with the public offering process.
Contact us for additional information.